LP208508-4
Hydroxyapatite
Active
Description
Hydroxylapatite, also called hydroxyapatite (HA), is a naturally occurring mineral form of calcium apatite with the formula Ca5(PO4)3(OH). HA crystal deposition disease (HADD) is a systemic disease of unknown etiology associated with para-articular and or intra-articular deposition of HA crystals. HADD is clinically manifested by localized pain, swelling, and tenderness about the affected joint along with variable limitation of joint motion. When intra-articular, HA crystals can cause joint destruction. Any joint can be involved; the shoulder is most commonly affected, resulting in "Milwaukee shoulder." Treatment includes analgesics, local heat, needling with or without aspiration of the calcific deposits, steroid injections, and possibly surgery for relief of pain. PMID: 14593560 Source: Regenstrief LOINC, PMID: 14593560
Basic Part Properties
- Part Display Name
- Hydroxyapatite
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2016-03-21
- Construct for LOINC Short Name
- Hydroxyapatite
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP208508-4 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP208508-4
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 羟基磷灰石 Synonyms: 羟磷灰石; |
es-ES | Spanish (Spain) | Hidroxiapatita |
it-IT | Italian (Italy) | Idrossiapatite |
nl-NL | Dutch (Netherlands) | hydroxyapatiet |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright